Rebecca K. Wood

REBECCA WOOD is global co-leader of the firm’s Food, Drug and Medical Device (FDMD) practice, serves on Sidley’s Global Life Sciences Leadership Council, and leads Sidley’s Washington, D.C. Healthcare and FDMD group. Becky previously served as Chief Counsel (general counsel role) at the U.S. Food and Drug Administration (FDA).

Becky provides counsel on a wide range of contentious and non-contentious FDA regulatory, compliance, and litigation issues to companies and investors in the life sciences industry. Becky handles high-stakes and significant FDA matters, including FDA supervisory review, appeals, and hearings; gene therapy, cell therapy, and regenerative medicine regulatory and compliance issues; medtech, AI, and digital health regulatory and compliance issues; impact litigation involving FDA-regulated products; FDA and tort considerations regarding federal preemption; and First Amendment/free speech issues relating to promotional speech and commercial complaints. A significant aspect of her practice involves leading cross-disciplinary teams navigating regulatory, compliance, enforcement, and litigation matters involving FDA-regulated products.